David B. Donner

Affiliations: 
Indiana University, Bloomington, Bloomington, IN, United States 
Area:
Immunology, Oncology, Molecular Biology
Google:
"David Donner"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Antonia RJ, Karelehto E, Toriguchi K, et al. (2022) STAT3 regulates inflammatory cytokine production downstream of TNFR1 by inducing expression of TNFAIP3/A20. Journal of Cellular and Molecular Medicine. 26: 4591-4601
Chamberlain CE, German MS, Yang K, et al. (2018) A Patient-derived Xenograft Model of Pancreatic Neuroendocrine Tumors Identifies Sapanisertib as a Possible New Treatment for Everolimus-Resistant Tumors. Molecular Cancer Therapeutics
Depeille P, Henricks LM, van de Ven RA, et al. (2015) RasGRP1 opposes proliferative EGFR-SOS1-Ras signals and restricts intestinal epithelial cell growth. Nature Cell Biology. 17: 804-15
Ducker GS, Atreya CE, Simko JP, et al. (2014) Incomplete inhibition of phosphorylation of 4E-BP1 as a mechanism of primary resistance to ATP-competitive mTOR inhibitors. Oncogene. 33: 1590-600
Depeille P, Henricks LM, Ven Rvd, et al. (2014) Abstract LB-306: The Ras exchange factor RasGRP1 opposes proliferative EGFR-SOS1 Ras signals and restricts intestinal epithelial cell growth Cancer Research. 74
Farkas C, Martins CP, Escobar D, et al. (2013) Wild type p53 transcriptionally represses the SALL2 transcription factor under genotoxic stress. Plos One. 8: e73817
Farkas C, Martins C, Escobar D, et al. (2013) Abstract LB-51: p53 transcriptionally represses the SALL2 transcription factor under genotoxic stress. Cancer Research. 73
Ducker GS, Atreya CE, Simko J, et al. (2012) Effect of PIK3CA and KRAS mutations on sensitivity to ATP-competitive mTOR inhibitors in a primary xenograft model of colorectal carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 483
Lin CI, Barletta JA, Nehs MA, et al. (2011) Thyroid-specific knockout of the tumor suppressor mitogen-inducible gene 6 activates epidermal growth factor receptor signaling pathways and suppresses nuclear factor-κB activity. Surgery. 150: 1295-302
Mitra R, Guo Z, Milani M, et al. (2011) CYP3A4 mediates growth of estrogen receptor-positive breast cancer cells in part by inducing nuclear translocation of phospho-Stat3 through biosynthesis of (±)-14,15-epoxyeicosatrienoic acid (EET). The Journal of Biological Chemistry. 286: 17543-59
See more...